@article{b07a6af7d48e4a049d214b62aa3d8037,
title = "Early response evaluation and CEA response in patients treated in a Danish randomized study comparing trifluridine/tipiracil (TAS-102) with or without bevazicumab in patients with chemorefractory metastatic colorectal cancer (mCRC)",
author = "C. Qvortrup and M. Yilmaz and S. Moller and D. Zitnjak and L. Maltha and M. Krogh and Petersen, {L. Noergaard} and F. Hejlesen and Winther, {S. B.} and Thomsen, {K. G.} and P. Pfeiffer",
year = "2019",
month = oct,
doi = "10.1093/annonc/mdz246.094",
language = "English",
volume = "30",
pages = "233",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Heinemann",
number = "Suppl. 5",
note = "44th Congress of the European Society for Medical Oncology, ESMO ; Conference date: 27-09-2019 Through 01-10-2019",
}